H Dietzfelbinger

Cetuximab Plus Capecitabine and Irinotecan Compared With Cetuximab Plus Capecitabine and Oxaliplatin As First-Line Treatment for Patients With Metastatic Colorectal Cancer: AIO KRK-0104—A Randomized Trial of the German AIO CRC Study Group

Nicolas Moosmann, Ludwig Fischer von Weikersthal, Ursula Vehling‐Kaiser et al. · Journal of Clinical Oncology · 2011 · 117 citations

Medicine, Oncology, Pharmacology +14

Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer

Florian Lordick, Sylvie Lorenzen, Ursula Vehling‐Kaiser et al. · British Journal of Cancer · 2005 · 79 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma. German Low-Grade Lymphoma Study Group.

Michael Unterhalt, Richard Herrmann, Markus Tiemann et al. · PubMed · 1996 · 59 citations

Medicine, Oncology, Pharmacology +16

Bioavailability of bi- and trivalent oral iron preparations. Investigations of iron absorption by postabsorption serum iron concentrations curves.

H Dietzfelbinger · PubMed · 1987 · 29 citations

Agriculture, Nutrition, Nutritional Sciences +16

Correlation of capecitabine-induced skin toxicity with treatment efficacy in patients with metastatic colorectal cancer: results from the German AIO KRK-0104 trial

Sebastian Stintzing, Ludwig Fischer von Weikersthal, Ursula Vehling‐Kaiser et al. · British Journal of Cancer · 2011 · 29 citations · Full text

Medicine, Oncology, Pharmacology +17